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Acute adaptative changes to unilateral nephrectnmy in humans. Renal
function was monitored in 20, living—related kidney donors before and
after uninephrectomy. Urinary protein excretion and retinoid metabo-
lism respectively were studied in 10 and 6 of these donors. The
functional adaptation was characterized by an increase in glomerular
filtration rate and tubular function, which began in the first two days
after uninephrectomy. Changes in tubular function were also demon-
strated by significant increases in the urinary excretion of beta 2
microglobulin (/32M), retinol binding protein (RBP), kappa and lambda
light chains of immunoglobulins. In addition, a protein identical to or
homologous to cellular retinoic acid binding protein (CRABP), ap-
peared in the urine after nephrectomy. We did not find CRABP in serum
samples either before or after nephrectomy, suggesting that urinary
CRABP was synthesized by the remaining kidney. Increases in serum
levels of Vitamin A and RBP were also observed in the post-nephrec-
tomy period. These modifications in retinol metabolism suggest that
these substances could have a role as renotropic growth factors in
compensatory hypertrophy.
It seems likely that Aristotle had already observed compen-
satory renal hypertrophy after reduction in renal mass [1].
However, the mechanisms of this phenomenon remain obscure.
Macroseopically, unilateral nephrectomy is accompanied by an
increase in the weight of the remaining kidney; however, there
is disagreement on the onset of hypertrophy and on the se-
quence of the events leading to it [2—5]. Since functional
adaptation and compensatory hypertrophy both appear simul-
taneously after nephrectomy, it has been very difficult to
identify any causal relationship between the two phenomena.
Two hypotheses have been invoked to explain the cause for the
onset of compensatory hypertrophy. According to the first,
compensatory growth is controlled by an organ—specific hu-
moral substance [6—SI. The second hypothesis suggests that the
increased work load on the remaining kidney is the cause of
renal hypertrophy. In an experimental model of glomerulone-
phritis it has been demonstrated that there is a marked paral-
lelism between glomerular filtration rate and proximal tubular
reabsorption, even at the level of single nephron [9, 101. Since
structural changes in renal tissue are closely linked to functional
modifications, glomerulo-tubular balance might play an impor-
tant role in compensatory growth [11—141.
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In a two year prospective study we analyzed acute adaptative
changes in the remaining kidney after unilateral nephrectomy in
20 healthy volunteers. This study was done in two ways. First
we analyzed the conventional markers of renal function and
second we monitored and biochemically characterized specific
urinary proteins appearing after nephrectomy.
Methods
Renal function was monitored before and daily after unilat-
eral nephrectomy in 20 living—related kidney donors. The
subjects consisted of 13 women and 7 men with an average age
of 49 5 years. All donors were healthy volunteers, and had
not undergone any recent medical treatment. Kidney donation
was accepted only when the absence of proteinuria, hyperten-
sion or other signs of renal or vascular disease was verified. The
levels of urea (Urease-Berthelot), creatinine (Jaffe), sodium,
potassium, chloride, bicarbonate (atomic absorption spectro-
photometry), and total protein (Biuret) were monitored in
serum and urine samples. All these determinations were done
with a Greiner Electronics selective analyzer 0300 (Greiner—
Bibby, Switzerland). Blood pressure was determined twice
daily and the mean value was used. Glomerular filtration rate
was calculated as endogenous creatinine clearance (mllmin/1 .73
m2 body area). After the surgical procedure, patients daily
received intravenously three liters of 5% dextrose supple-
mented with 180 m sodium. On the third day perfusions were
stopped and oral nutrition was progressively reintroduced.
Protein studies
Protein preparation. Urinary proteins were studied in 10 of
our donors before, during and daily after nephrectomy. During
surgery, in order to collect the urine separately before and after
renal artery occlusion, the following procedure was done: a
bladder catheter with two different urine bags was applied just
after anaesthesia. While the two kidneys were still functioning,
a clamp was placed on the inlet of the first bag. When the renal
artery was ligatured by the surgeon, the clamp was placed on
the inlet of the second bag and the urine was collected in the
first one. Total protein concentration was estimated by Bradford's
method as modified by Spector [15]. Urine was concentrated
and desalted by a cuprophane dialyzer with a cut—off of 5000
daltons (DISCAP 110, Hospal Corporation, Basel, Switzer-
land). Dialysate used was deionized water. The concentrated
urine was lyophilized and stored at —20°C until analysis.
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Table 1. Renal function evolution after nephrectomy in kidney donors
Days
Before 1 2 3 4 5 6 7 10 12
Serum creatinine /.LM/liter 87 145 148 142 149 138 131 133 125 114




4 6.5 7.604b 7.3÷04b 8.1÷04b 7.2
6.5
Creatine clearance 100 47 63 62 59 59 56 63 61 63
mllmin/1.73 10b ÷14b 10b 9b
Fractional ex Na % 1.1 4.1 2.9 2.7 2.1 1.2 1.1 0.9 1.1 1.1
Fractional ex K % 11 34 20 22 16 13 15 15 15 15
Protein excretion mg/24 h 83 644 911 828 990 318 453 456 356 212
Syst. blood pres. mm Hg 125 135 138 131 127 125 126 115 117 117
Dias. blood pres. mm Hg 73 75 79 78 74 76 72 68 63 67
a j < 0.05
b P < 0.01
Urinary proteins excreted before and after surgical procedure
were studied in a control group of six patients who underwent
a non-urologic surgical procedure.
Monodimensional electrophoresis. Proteins (1 mg) were sol-
ubilized in 100 ,td of 6 M urea, 5 mrvi dithiothreitol (DTF), 1%
sodium dodecyl sulfate (SDS) and 50 mM Tris Hcl pH 6.8 and
centrifuged at 10.000 rpm for two minutes. The supernatant (50
.d) were analyzed for sodium dodecyl sulfate 5 to 15% (wt/vol)
polyacrylamide gel electrophoresis (SDS-PAGE) performed
using a discontinuous buffer system [161. The apparent molec-
ular weight were determined in SDS electrophoresis by co-
migration of standard markers (alpha-lactalbumin (14.4 kD),
soybean trypsin inhibitor (20.1 kD), carbonic anhydrase (30
kD), ovalbulmin (43 kD), bovine serum albumin (67 kD) and
phosphorylase b (94 kD). Gels were stained with Coomassie
Blue.
Two—dimensional polyacrylamide—gel electrophoresis (PAGE).
The electrophoresis was conducted as described by O'Farrell
[171. Proteins (350 g) solubilized in 100 1.d of 9.5 M urea, 10%
(vol/vol) Nonidet P-40, 0.1 mri DTT and ampholine mixture (2
to 11 pH range) were used.
Immunological techniques (Western Blotting). Rabbit anti-
bodies against /32M and globin chains were purchased from
BlO-YEDA Laboratories (Rehovot, Israel). Antibodies against
retinol binding protein (RBP) were obtained from Behring
Institute (Mannheim, West Germany). Antibodies against lambda
and kappa light chains were kindly supplied by Blood Center of
Montpellier (France). Protein transfer from SDS-PAGE to nitro
cellulose sheets (0.45 .tm thick) was performed according to
Burnette [18] with the addition of 0.2% SDS to the transfer
medium. Specific immune reactions were revealed by anti-
rabbit IgG conjugated with peroxidase.
Metabolism of vitamin A
Metabolism of vitamin A was investigated in six of our
donnors by the following means:
Determination of 3H retinoic acid binding in urinary pro-
teins. 11-12 (3H) All—trans-retinoic (specific activity 16.3 Cit
mmol) was from Hoffmann La Roche (Basel, Switzerland).
Retinoic acid (RA) was obtained from Sigma. All experiments
were performed at 0°C under red light. Lyophilized urinary
proteins obtained before and during the first day after renal
artery occlusion were analyzed. Proteins (800 p.g) were solubi-
lized in 0.4 ml of TNE buffer (50 mi.i Tris HC1, 25 mM NaCI, 2
mM dithioerythritol, pH 7.4) and were incubated one hour with
S nM 3H-RA in the presence or absence of 1000-fold molar
excess of unlabeled RA. At the end of the incubation period a
0.15 ml aliquot of the reaction mixture was withdrawn and
stirred with 0.075 ml of dextran coated charcoal (DCC, 0.5%
dextran, and 5% activated charcoal in TNE buffer) for 10
minutes. The mixture was centrifuged for one minute in a
Beckman microfuge and radioactivity in the supernatant was
determined with liquid scintillation counter (Betamatic Kontron)
using hydroluma counting solution (10 ml, Kontron). The
specific binding of 3H-RA was calculated by subtracting the
non-specific binding estimated in the presence of 1000-fold
molar excess of unlabeled RA from total binding. Remaining
supernatant was analyzed for protein composition by gel filtra-
tion.
Identjfication of retinoic acid binding protein. Chromatogra-
phy of protein samples demonstrating RA binding activity was
accomplished by high performance gel filtration. A FPLC
system (Pharmacia) equipped with a HR 10/30 Superose 12 gel
filtration column (Pharmacia) was used with a mobile phase
buffer 20 mM K2FIPO4, 0.2 M KCI, pil 7.0 (filtered on 0.2
Millipore filter). The labeled supernatants remaining from the
3H-RA binding studies (200 ,Ld) were injected onto the column
and chromatographed at a flow rate of 0.3 ml/mn at 4°C in a
darkroom. Absorbance was monitored at 280 nm and 80 frac-
tions of 0.33 ml each were collected.
Monitoring of serum retinoids. RBP was determined by
single radial immunodiffusion as described by Mancini, Carbon-
ara and Heremans [19]; antibodies were purchased from Behr-
ing Institute (Mannheim, West Germany). Vitamin A was

















Fig. 1. Monitoring of urinary protein
excretion before and daily after nephrectomy
by gel electrophoresis 0.1% SDS, 15% (wtlvol)
polyacryla,nide (A), and two—dimensional
electrophoresis of the first day after
nephrectomy (B).
monitored in serum samples before and daily after uninephrec-
tomy. Identical determinations were done in the control group.
Statistical analysis
Statistical analysis was performed with an IBM 308 l-D2
computer using SAS package [21]. T-paired test was used for
comparison of paired data in the longitudinal analysis. P values
less than 0.05 were considered significant. The results were
given as mean standard error of the mean.
Results
Adaptative changes in renal function
The course of serum creatinine, serum urea, creatinine clear-
ance, fractional excretion of sodium and potassium, daily
urinary protein excretion, as well as systolic and diastolic blood
pressure is shown in Table 1. These data are in accordance with
earlier studies [5, 22].
Urinary protein excretion
Analyses by SDS-PAGE of urinary proteins excreted by the
ten donors before kidney removal showed a normal profile. The
same analyses made after uninephrectomy displayed the imme-
diate appearance of new protein bands with apparent mol wt of
12 kD, 14 kD, 25 kD, 28 kD, and 30 kD (Fig. 1A). These major
bands were consistently found in the urine from all donors.
Return to the pre-nephrectomy protein pattern was observed 7
to 10 days after nephrectomy. The control group did not
demonstrate these modifications in urinary proteins. Monitor-
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Fig. 2. Western blotting of urinary proteins excreted by kidney donors
after uninephrectomy. The four bands of antigen—antibody reaction
were observed after incubation with polyclonal antibodies against beta
2 microglobulin (D), retinol binding protein (C), kappa (B) and lambda
(A) light chains of immunoglobulins, respectively, from left to right
side. E lane is the sheet incubated with anti-globin chains. Note that
A—D had a positive reaction, while E had not.
ing of serum proteins in kidney donors after nephrectomy did
not reveal any major changes.
The urinary proteins appearing after nephrectomy were char-
acterized by two—dimensional electrophoresis. On the basis of
their molecular weight and isoelectric point we considered that
the 12, 25, 28, and 30 kD could be p2M, RBP, kappa, and
lambda immunoglobulin light chains, respectively (Fig. IB). In
order to confirm this protein identification, immunodetection
using polyclonal antibodies was performed. Among the five
major protein bands appearing after nephrectomy four gave a
positive response respectively with anti-f32M, anti-RBP, anti-
kappa, and anti-lambda light chains of immunoglobulins (Fig. 2,
lanes A, B, C, D). The protein of 14 kD was not identified;
based on molecular weight estimation we incubated the trans-
ferred proteins with antibodies directed against globin chains,
but there was no antigen—antibody reaction (Fig. 2, lane E); this
result demonstrated that the 14 kD band did not contain globin
chains.
Cellular retinoic acid binding protein (CRABP) is a 14 kD
protein which specifically binds retinoic acid 23]. In order to
investigate if the observed 14 kD band could correspond to
CRABP we performed binding studies on samples of urinary
and serum proteins using 3H-RA. Serum proteins did not show
any specific binding of 3H-RA either before or after nephrec-
tomy. Urinary proteins from donors before nephrectomy also
did not specifically bind 3H-RA. In contrast, urinary proteins
excreted after nephrectomy specifically bound retinoic acid.
Table 2 shows the percentage of specific binding of urinary
proteins excreted at day 1 after surgery in donors and controls.
Proteins incubated with 3H-RA in the presence and in the
absence of 1000-fold molar excess of unlabeled retinoic acid,
Table 2.
one day
Specific binding of excreted urinary proteins to retinoic acid
after nephrectomy (donors group) or one day after another
surgical procedure (control group)
Donors group Control group
Surgery














Abbreviations are: Nx, uninephrectomy; C.B.P., coronary by pass;




after a 10 minute period with dextran coated charcoal, were
subjected to high performance gel filtration (Fig. 3). A major
peak of radioactivity was identified, corresponding to a stokes
radius of 14 A. It was abolished when experiments were
performed in presence of unlabeled retinoic acid in l0 molar
excess. Molecular weight determination assuming that the
protein is globular, was calculated at 14 kD.
Study of retinoids in serum
The levels of both serum vitamin A and serum RBP increased
in the donors group after nephrectomy when compared to the
20 40 60 80
Fraction number
Fig. 3. Ge/filtration of the labeled urinary proteins of the first postop-
erative day on HR 10/30 superose 12 in presence (—0—) or absence
(——) ofunlabeled retionic acid. The standard markers indicated at top
of the figure are: thyroglobulin (330 kD), bovine albumin (67 kD),
ovalbumin (43 kD), chymotrypsinogen (25 kD), and ribonuclesase (13.7
kD).
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Table 3. Modification of serum retinoids following uninephrectomy
(donors group, N = 6) and surgical procedure other than
nephrectomy (control group, N = 6)
Donors group Control group
Day 7—before N = 6 N = 6
R.B.P.
mg/liter +29 6.5 —16.5 6
P < 0.020 P < 0.04
Vit A
/Lmol/liter +0.85 0.2 —1.57 0.5
P<0.007 P<0.04
The differences between pre- and post-surgery (day 7) mean levels
are given (mean SEM). Student's t-test for paired data was used.
prenephrectomy values. All post-nephrectomy values mea-
sured daily were higher than pre-nephrectomy and had statisti-
cal significance at hour 12, and days 6, 7 and 8. The monitoring
of the control group showed an opposite tendency: Vitamin A
and RBP values were significantly lower at day 7 post-surgery
than during the pre-operative course (P < 0.04 for both Vit A
and RBP) (Table 3).
Discussion
After a decrease of 53% in glomerular filtration rate second-
ary to kidney removal, the glomerular adaptation phenomenon
was characterized by an increase to 63% of prenephrectomy
value at day 12. With regards to tubular adaptation, our data
showed a sharp increase in fractional excretion of sodium and
potassium. In the second week fractional excretion of sodium
and potassium returned to the preoperative values. These
findings confirmed earlier data of functional adaptation to
uninephrectomy [5, 221.
Uninephrectomy was associated with the appearance of low
mol wt proteins in the urine (/3M, RBP, lambda and kappa light
chains of immunoglobulins), which appeared in significantly
greater amounts than under normal conditions. These were
identified by Western blots. Indeed, other plasmatic proteins
normally present in urine were observed by two—dimensional
electrophoresis as shown in Figure 1B: albumin, transferrin,
Tamm—Horsfall protein, hemopexin, and others. Since all these
proteins excreted by the kidney are plasmatic and often syn-
thesized in the liver, it would be difficult to identify a renal
synthesis of these plasmatic proteins. According to classifica-
tions of urinary proteins, the pattern we obtained can be
considered as tubular, suggesting that the filtered proteins were
not completely reabsorbed by the tubule [24, 25]. Furthermore,
the total daily protein—excretion did not reach 2 g/day, a level
corresponding to a proteinuria of tubular type. Nevertheless,
the daily protein excretions were higher than expected; this
could be due, at least in part, to the high sensitivity of
Bradford's assay we used to evaluate urinary protein concen-
tration. Urinary protein excretion determined by autoanalyzer
in the same samples did not show such a great increase. The
maximum level of daily protein excretion was reached at days 2
to 4. Subsequently protein excretion decreased in a parallel way
to fractional excretion of sodium, but remained at a higher level
than preoperative. Previously, a trend towards increased daily
protein excretion has been observed in long—term postnephrec-
tomy patients [26—29]. The daily protein excretion rate that we
found at day 12 after nephrectomy is similar to that we reported
in long—term uninephrectomized patients [26]. It is important to
stress that we never observed a glomerular type of proteinuria
in any of our patients. As unilateral nephrectomy is followed by
important glomerular and tubular function modifications, the
renal handling of proteins is also strongly modified, with the
appearance of a tubular pattern proteinuria which decreased
after the sixth day.
The identification of proteins appearing after nephrectomy
was done in order to demonstrate some metabolic activity
which could be related to compensatory renal growth. On this
sense, f32M, lamba and kappa light chains of immunoglobulins
was not interesting. The RBP found in large amounts in the
urine does not have metabolic activities by itself but is the
plasma carrier of retinol [30]. RBP is a classical marker used to
assess tubular proteinuria [31]. It is known that retinoids have
metabolic activities related to trophic cellular imbalance and
hyperplasia [32, 331. Though controversial, some of these are
well established. (1) Retinoids are necessary to functional and
morphological integrity of epithelial tissues [34]. (2) Retinoids
increase DNA synthesis and growth as well as epithelial mitotic
index [34, 35]. (3) In cellular culture systems retinoids increase
total amount of RNA by 40%, DNA by 18%, and protein
synthesis by 13% [36]. (4) Retinoids prevent metaplasia of
cutaneous, gastrointestinal, respiratory and urogenital epithe-
liae, and have been proposed in therapy and prevention of
neoplasias [37]. In this study, one of the excreted proteins had
a molecular weight of 14 kD as determined by SDS-PAGE and
high—performance gel filtration. This correspond to the pub-
lished molecular weight for CRABP. Retinoids induce increases
in mRNA, DNA and protein synthesis [34-36, 38, 39] similar to
those found in hypertrophy phenomenon [36, 40] and particu-
larly in compensatory kidney growth [41]. The increase in
mRNA is greater than that for DNA in contrast to hyperplasia
where the increase in DNA is greater than the increase in
mRNA. Therefore, we decided to investigate a hypothetical
participation of retinoids in the adaptative events occurring
after nephrectomy. Our studies in which the 14 kD protein was
shown to bind 3H-RA suggest that this protein appearing after
nephrectomy could be identical or homologous to CRABP.
Such a protein was present in the urine of all studied donors and
absent in the control group. In the absence of hematuria or
leucocyturia, two hypotheses could be formulated to explain
the presence of CRABP in the urine: lysis of renal cells with
subsequent CRABP leakage, or an increased production of
CRABP. There was no clinical evidence for lysis of tubular
cells. In regards to the later, CRABP is present in tubular cells
[42], but normally absent in the urine. We could consider that
during the first days after nephrectomy (up to 5 to 7) the
production of CRABP by the tubular cells is sufficiently high to
spill over in the urine. Afterwards, despite the continuation of
hypertrophic processes, CRABP was not excreted in the urine.
However, our studies give no information about cellular levels
of CRABP.
Subsequently, we monitored serum retinoids in six donors
and observed a significant increase in their levels which con-
firmed a modification of retinoid metabolism after nephrec-
tomy. The major increase of retinoids was observed at days 5,
6, 7, and 8 after nephrectomy. Yamada et al demonstrated that
serum of uninephrectomized patients induces an increased
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incorporation of thymidine into DNA in cultured kidney cells
[43]; this later increase reached a maximum level between days
5 and 7 [43, 44]. The retinoids could be one of the renotropic
factors monitored by Yamada et al 1431.
The presence of renal growth factor(s) in mice urine have
already been reported. They are poorly dialyzable (mol wt> 10
kD) and are thought to have an extrarenal origin [451. On the
other hand, the appearance of CRABP in the urine specifically
after nephrectomy and its absence from serum either before or
after surgical procedure suggest that local renal modifications
are responsible for CRABP excretion. Since CRABP is sup-
posed to modulate the activity of retinoic acid on the cell [46],
changes in levels of CRABP could modify the renal response to
retinoic acid. The increase in renal CRABP could sensitize the
kidney cells to retinoic acid, which is the most active growth
factor of retinoids [33]. This is in agreement with the theory that
suggests an increased sensitivity to circulating growth factor(s),
secondary to local modifications as a cause of renal hypertro-
phy [47]. Such a mechanism has been described in a study of
myocardial hypertrophy, where the authors showed an in-
creased protein synthesis by the cell when aortic pressure rose
[48]. Monitoring of the control group showed neither an in-
crease in serum retinoids nor any specific binding for retinoic
acid by urinary proteins. We concluded therefore, that modifi-
cations in retinoid metabolism were specifically due to unineph-
rectomy and not to surgical procedure.
The findings reported here permit us to propose the following
pathway for the compensatory hypertrophy mechanism: Renal
artery occlusion and nephrectomy produces functional alter-
ations in the remaining kidney, which locally modify the CRABP
metabolism. This modification sensitizes the remaining kidney
to increased serum retinoids, which in turn stimulate growth
activity. A recent study [49] showing that the remaining kidney
is able to synthesize the insulin like growth factor I (ILGF I)
independently of humoral regulation is consistant with this
mechanism.
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